Irish design and innovation SME with expertise in biomaterial risk assessment, microfluidics, and industrial partnering in clean energy training networks.
Dolmen Design and Innovation is an Irish SME that contributes product design, innovation methodology, and industry-facing expertise to EU research consortia spanning biomedical and clean energy domains. In PANBioRA, they worked alongside academic and clinical partners on developing personalized biomaterial risk assessment tools — an area requiring close integration of design thinking with microfluidics, cytotoxicity testing, and real-time monitoring. In eSCALED, they participated as an industrial partner in an MSCA training network focused on artificial photosynthesis and solar energy materials, likely offering early-stage researchers exposure to commercial product development pathways. Their pattern across both engagements suggests a firm that positions itself as the industry bridge in research-heavy consortia — translating scientific outputs toward manufacturable, standardizable solutions.
PANBioRA (2018–2021) involved personalised risk assessment, cytotoxicity, genotoxicity, and biomaterial-tissue interactions — a technically demanding regulatory and product-design challenge.
PANBioRA keywords include microfluidics and real-time monitoring, suggesting Dolmen contributed to device-level design or integration within the biomaterial testing platform.
eSCALED (2018–2022) covered artificial photosynthesis, organic solar cells, perovskite, and solar fuels — domains in which Dolmen served as an industrial partner in a Marie Skłodowska-Curie training network.
Their company name and consistent participant/partner roles across two structurally different projects indicate a core competency in design and innovation process rather than narrow technical specialisation.
Both H2020 projects began in 2018, so a true chronological evolution is difficult to establish — this organisation's H2020 footprint is a single funding wave rather than a multi-year trajectory. That said, the two projects cover strikingly different scientific domains: PANBioRA sits in biomedical manufacturing (safety testing, immune response, microbiota), while eSCALED sits in advanced energy materials (photosynthesis, solar fuels, semiconductors). Rather than a sequential shift, this suggests Dolmen operates as a deliberately sector-agnostic innovation partner, engaging where design and commercialisation expertise is needed regardless of the underlying science.
With both projects launched in the same year across unrelated scientific domains, Dolmen appears to pursue an opportunistic, generalist innovation-partner strategy — future collaborations could emerge in any sector where an Irish SME with design and commercialisation capability is a consortium requirement.
Dolmen has never coordinated an H2020 project, always entering as a participant or third-party partner — a pattern consistent with a specialist contributor that adds value within consortia led by research institutions. Their involvement in PANBioRA, a large multi-partner RIA, and eSCALED, an MSCA training network, shows comfort operating in complex, multinational teams without needing to drive the agenda. For potential partners, this means Dolmen is likely a low-friction consortium member focused on delivering a specific contribution rather than competing for project governance.
Despite only two projects, Dolmen has connected with 33 unique consortium partners across 15 countries — a wide footprint driven primarily by PANBioRA's large multinational structure. No geographic concentration is evident; their network is broadly European.
Dolmen occupies an unusual space as a small Irish design and innovation firm that has successfully positioned itself as an industry partner in both a biomedical safety consortium and a clean energy training network — two domains with very little overlap. This sector flexibility is rare among SMEs of their size and may reflect a deliberate strategy to offer design-and-commercialisation expertise as a horizontal capability. For consortium builders needing an Irish SME voice with a credible innovation track record across manufacturing and energy, Dolmen represents a compact, versatile option.
